🔴 Veraxa Biotech is trading 5% down with no clear catalyst identified

Veraxa Biotech is trading 5.1% lower at $1.30 on September 29, 2026, with no clear company-specific catalyst identified.

• Shares closed at $1.37 on September 28, after several sessions of weakness.
• Recent coverage discussed the oncology pipeline and CFO appointment but did not link them to the decline.
• Supplied indices were down less than 0.5%, and available evidence identifies no definite catalyst.